Streetbeat News

Price Targets

ALLO

Oppenheimer analyst Matthew Biegler assumes coverage of Allogene Therapeutics (NASDAQ:ALLO) with an Outperform rating but lowers the price target to $11.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:17 pm

EYE

UBS analyst Michael Lasser maintains a Buy rating on National Vision Holdings (NASDAQ:EYE) but lowers the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:17 pm

Z

Wedbush analyst Jay McCanless has reiterated a Neutral rating on Zillow Group (NASDAQ:Z) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:11 pm

EOG

UBS analyst Josh Silverstein maintains a Buy rating on EOG Resources (NYSE:EOG) but lowers the price target from $169 to $166.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:10 pm

DT

Wedbush analyst Taz Koujalgi has reiterated a Neutral rating on Dynatrace (NYSE:DT) and maintained a $55 price target.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:09 pm

APP

Wedbush analyst Nick McKay maintains an Outperform rating on AppLovin (NASDAQ:APP) but lowers the price target from $100 to $90.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:08 pm

DIS

UBS analyst John Hodulik maintains a Buy rating on Walt Disney (NYSE:DIS) but lowers the price target from $130 to $120.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:06 pm

DIN

UBS analyst Dennis Geiger maintains a Buy rating on Dine Brands Global (NYSE:DIN) but lowers the price target from $56 to $51.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:05 pm

CF

CF Industries Holdings shares are trading higher following the release of better-than-expected Q2 financial results. UBS maintained a Neutral rating on the stock but raised its price target from $78 to $80.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 2:01 pm